Prostatis Group’s Goldman Sachs GS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$823K Sell
972
-24
-2% -$21.4K 0.21% 82
2025
Q4
$875K Buy
996
+324
+48% +$264K 0.21% 78
2025
Q3
$535K Sell
672
-53
-7% -$39.3K 0.13% 94
2025
Q2
$513K Sell
725
-255
-26% -$148K 0.15% 95
2025
Q1
$536K Sell
980
-96
-9% -$57.8K 0.17% 91
2024
Q4
$616K Buy
1,076
+29
+3% +$16.2K 0.18% 92
2024
Q3
$518K Sell
1,047
-8
-0.8% -$3.91K 0.17% 92
2024
Q2
$477K Sell
1,055
-71
-6% -$31.2K 0.17% 98
2024
Q1
$470K Buy
1,126
+65
+6% +$25.2K 0.18% 96
2023
Q4
$409K Buy
1,061
+123
+13% +$41.1K 0.17% 94
2023
Q3
$334K Sell
938
-11,267
-92% -$3.76M 0.16% 77
2023
Q2
$218K Buy
12,205
+11,583
+1,862% +$3.81M 0.1% 105
2023
Q1
$201K Sell
622
-120
-16% -$41.8K 0.11% 96
2022
Q4
$255K Sell
742
-40
-5% -$13.9K 0.16% 86
2022
Q3
$229K Sell
782
-26
-3% -$8.42K 0.26% 57
2022
Q2
$240K Buy
808
+94
+13% +$29.3K 0.37% 37
2022
Q1
$236K Buy
714
+1
+0.1% +$353 0.19% 70
2021
Q4
$273K Buy
713
+1
+0.1% +$396 0.17% 82
2021
Q3
$269K Buy
712
+17
+2% +$6.64K 0.16% 82
2021
Q2
$264K Buy
+695
New +$249K 0.18% 86

Other funds holding GS

Prostatis Group's GS Position: Q1 2026 in Review

Prostatis Group reduced its Goldman Sachs (GS) stake by 2.4% in Q1 2026, selling an estimated $21.4K and leaving 972 shares worth $823K. The position accounts for 0.21% of the portfolio, ranked #82.

Prostatis Group first reported a position in GS in Q2 2021 and has held it in 20 quarters since. The position peaked at $875K in Q4 2025. 2,981 funds tracked by Wall St. Rank hold GS as of Q1 2026.

  • Prostatis Group held 972 shares of Goldman Sachs worth $823K as of Q1 2026.
  • Prostatis Group sold 24 Goldman Sachs shares in Q1 2026, an estimated $21.4K.
  • Goldman Sachs made up 0.21% of Prostatis Group's portfolio in Q1 2026, its #82 holding.
  • Prostatis Group first reported a position in Goldman Sachs in Q2 2021 and has held it in 20 quarters since.
  • Prostatis Group's Goldman Sachs position peaked at $875K in Q4 2025.
  • 2,981 funds tracked by Wall St. Rank held Goldman Sachs as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.